Medmen Posts Q4 Loss Of $46.2 Million
Medmen Enterprises (CSE: MMEN) last night reminded investors why Canaccord Genuity had a long standing $0.00 price target on the
Read more
Tilray
Tilray: Cantor Lowers Price Target, Walks Back Coca-Cola Comments
Last week, Cantor Fitzgerald updated their estimates on a bundle of Canadian License Producers. In every case, they slashed the
Read more
Tilray Sees Gotham Green Look To Sell Recently Acquired Shares
It appears that Gotham Green Partners has approximately zero interest in being a shareholder of Tilray Inc (TSX: TLRY) (NASDAQ:
Read more
Democrats Take Aim At “Big Cannabis” In Proposed CAOC Legislation
It appears that the federal legalization of cannabis in the United States might not be in the best interest of
Read more
Tilray: Analysts Leave Targets Unchanged After MedMen Investment
On August 17, Tilray (NASDAQ: TLRY) made the announcement that they formed a new limited partnership with other strategic investors,
Read more
Tilray Makes Move Into US Cannabis Market Via Medmen Convertible Notes
It appears that the rumours surrounding Tilray’s (NASDAQ: TLRY) focus on the US cannabis market were true. The firm this
Read more
Tilray Reports FY2021 Results: US$513.1 Million In Revenue, US$336.0 Million Net Loss
Tilray Inc. (TSX: TLRY) released yesterday morning its full-year financial results for the 2021 fiscal year ending May 31, 2021,
Read more
Tilray: Fourth Quarter Consensus Estimates
Tilray (TSX: TLRY) (NASDAQ: TLRY) will be reporting its fourth quarter financial results on July 28 before the market opens.
Read more
Federal Wage Subsidies Granted to Publicly Traded Cannabis Companies Eclipses $100 Million
On June 1, 2021, total wage subsidies doled out to publicly traded cannabis companies from the Canada Emergency Wage Subsidy
Read more
Tilray: Haywood Reiterates Hold Rating, $16.50 Price Target
With the Aphria, Tilray (NASDAQ: TLRY) merger finalized and Aphria shares consolidated earlier this month, many analysts are now updating
Read more